Home » Topics » BioWorld Science

BioWorld Science
RSS

Iterum reports topline data from phase III trial of sulopenem in cIAI

Dec. 11, 2019

hSTING agonists described in Incyte patent

Dec. 11, 2019

University of Texas System identifies KRAS-targeting compounds

Dec. 11, 2019

Alligator initiates first-in-human study of 4-1BB antibody ATOR-1017

Dec. 11, 2019

VenatoRx Pharmaceuticals patent details bacterial PBP3 inhibitors

Dec. 11, 2019

Primmune Therapeutics discloses new TLR7 agonists

Dec. 11, 2019

Constellation Pharmaceuticals patents EZH2 inhibitors

Dec. 11, 2019

Xeris reports in-clinic stage data from phase II trial of RTU glucagon

Dec. 11, 2019

Three phase III trials of tralokinumab in atopic dermatitis meet endpoints

Dec. 11, 2019

GenSight reports on REALITY registry study in support of Lumevoq

Dec. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...